Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Liver Neoplasms × Polyethylene Glycols × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 6 Inflammatory Bowel Diseases 3 Colonic Polyps 3 Colonic Neoplasms 3 Surgical Wound Infection 2 Neoplasms 2 Melanoma 2 Carcinoma, Hepatocellular 2 Uveal Melanoma 1 Sarcoma 1 Rectal Neoplasms 1 Polyps 1 Ovarian Neoplasms 1 Opioid-Induced Constipation 1 Lymphoma, Non-Hodgkin 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Intestinal Neoplasms 1 Gastrointestinal Hemorrhage 1 Diverticulitis 1 Cancer Pain 1 Adenoma 1

Interventions

Sorafenib 57 Bevacizumab 36 Oxaliplatin 24 Fluorouracil 20 Doxorubicin 19 durvalumab 17 Nivolumab 17 Gemcitabine 17 pembrolizumab 16 Radiosurgery 16 Radiofrequency Ablation 16 Cisplatin 15 lenvatinib 14 Capecitabine 14 Leucovorin 13 atezolizumab 11 tremelimumab 10 Radiotherapy 10 Cyclophosphamide 10 Irinotecan 9 Carboplatin 9 Ipilimumab 8 Drug Therapy 8 Cryosurgery 8 fludarabine 7 Everolimus 7 Chemotherapy, Adjuvant 7 toripalimab 6 Sunitinib 6 Melphalan 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02006030 2018-09-04

TACE

Polaris Group

Phase 2 Completed

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡